PERSISTENCE OF LYSERGIC ACID DIETHYLAMIDE IN THE PLASMA OF HUMAN SUBJECTS.
about
The pharmacology of lysergic acid diethylamide: a review.Psychedelics and Immunomodulation: Novel Approaches and Therapeutic OpportunitiesComa, hyperthermia and bleeding associated with massive LSD overdose. A report of eight cases.The stimulus properties of LSD in C57BL/6 mice.Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans.LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex.Use of anti-epileptic medication in treating "flashbacks" from hallucinogenic drugsPharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.Development and validation of an ultra-fast and sensitive microflow liquid chromatography-tandem mass spectrometry (MFLC-MS/MS) method for quantification of LSD and its metabolites in plasma and application to a controlled LSD administration study iDoes LSD induce chromosomal damage and malformations? A review of the literature.Saliva testing for drugs of abuse.Coma, hyperthermia, and bleeding associated with massive LSD overdose, a report of eight cases.Development and validation of a rapid turboflow LC-MS/MS method for the quantification of LSD and 2-oxo-3-hydroxy LSD in serum and urine samples of emergency toxicological cases.Regional localization of lysergic acid diethylamide in monkey brain.Bifunctional N-acyl-aminophosphine-catalyzed asymmetric [4+2] cycloadditions of allenoates and imines.
P2860
Q22242295-08713075-C2C4-449C-B1A8-D93F91C085D3Q26799997-A60B3E41-B331-4148-AE30-576A6A5A5400Q28769673-B63DA6B2-CC0B-4900-B1CA-E73917A5D35BQ34312785-1DF665BE-E3A3-4B8F-8681-301888CD3158Q34482174-00A91CBE-0DED-4C68-9868-AF0C432C5386Q34505229-A82D2C3B-CA7C-4294-A184-22B76CAF5851Q35911285-8094EA21-5F85-4ED9-93A0-B55737DB0596Q38961114-28446668-80E8-44BC-9A4D-1A788A9B59EAQ39597242-48922337-FA79-4C33-B6A0-04ACDCE6DED7Q39956066-511312F7-C3F7-4B72-98D7-A8FD7A1BB6A9Q40769040-EDB121E0-5459-4705-878A-94DAB2DF3924Q40899707-1309DB33-CD2C-4AF7-8523-B233757C1915Q41647007-CFCCFD10-6D3E-4F6E-A4E0-00FD4C586400Q51237856-442FBFF8-C47C-4FB4-87DC-157CC44A717BQ52726187-7A38827E-E9B5-44CD-BC8A-54F79BA52E9D
P2860
PERSISTENCE OF LYSERGIC ACID DIETHYLAMIDE IN THE PLASMA OF HUMAN SUBJECTS.
description
1964 nî lūn-bûn
@nan
1964 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1964 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1964年の論文
@ja
1964年論文
@yue
1964年論文
@zh-hant
1964年論文
@zh-hk
1964年論文
@zh-mo
1964年論文
@zh-tw
1964年论文
@wuu
name
PERSISTENCE OF LYSERGIC ACID DIETHYLAMIDE IN THE PLASMA OF HUMAN SUBJECTS.
@ast
PERSISTENCE OF LYSERGIC ACID DIETHYLAMIDE IN THE PLASMA OF HUMAN SUBJECTS.
@en
PERSISTENCE OF LYSERGIC ACID DIETHYLAMIDE IN THE PLASMA OF HUMAN SUBJECTS.
@nl
type
label
PERSISTENCE OF LYSERGIC ACID DIETHYLAMIDE IN THE PLASMA OF HUMAN SUBJECTS.
@ast
PERSISTENCE OF LYSERGIC ACID DIETHYLAMIDE IN THE PLASMA OF HUMAN SUBJECTS.
@en
PERSISTENCE OF LYSERGIC ACID DIETHYLAMIDE IN THE PLASMA OF HUMAN SUBJECTS.
@nl
prefLabel
PERSISTENCE OF LYSERGIC ACID DIETHYLAMIDE IN THE PLASMA OF HUMAN SUBJECTS.
@ast
PERSISTENCE OF LYSERGIC ACID DIETHYLAMIDE IN THE PLASMA OF HUMAN SUBJECTS.
@en
PERSISTENCE OF LYSERGIC ACID DIETHYLAMIDE IN THE PLASMA OF HUMAN SUBJECTS.
@nl
P356
P1476
PERSISTENCE OF LYSERGIC ACID DIETHYLAMIDE IN THE PLASMA OF HUMAN SUBJECTS.
@en
P2093
AGHAJANIAN GK
P304
P356
10.1002/CPT196455611
P407
P577
1964-09-01T00:00:00Z